Marksans Pharma share price slumps 14% to four-month low after weak Q1 results

Marksans Pharma shares fell 14.28% to ₹180 following a 35.8% YoY drop in net profit to ₹58.2 crore due to weak performances in key regions. Despite challenges, total revenue increased 5% YoY to ₹620 crore, bolstered by a 30.6% revenue rise in the US market.

Markets